Pure Global
NCT01884649

Fetuin A in Hashimoto Thyroiditis

Fetuin A as a New Marker of Inflammation in Hashimoto Thyroiditis
Istanbul Medeniyet University·ClinicalTrials.govCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hashimoto Thyroiditis
Study type
Observational
Sponsor & location
Primary sponsor
Istanbul Medeniyet University
Timeline & enrollment
Phase
N/A
Start date
May 01, 2012
End date
Oct 01, 2012
Enrollment
97 participants
Primary outcome

Comparison of serum fetuin A levels between patients with Hashimoto thyroiditis and healthy subjects

Summary

Fetuin-A levels are reported to be low as a negative acute phase reactant in systemical
 inflammatory situations. Hashimoto thyroiditis is characterized with inflammation. In this
 study, we hypothesised that the serum fetuin A levels could be found to be low due to
 inflammation in patients with Hashimoto thyroiditis

ICD-10 classifications
ThyroiditisThyroiditis, unspecifiedDisorders of thyroid glandDisorder of thyroid, unspecifiedOther disorders of thyroid
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT01884649
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT01884649 through Pure Global AI's free database. This phase not specified trial is sponsored by Istanbul Medeniyet University and is currently Completed. The study focuses on Hashimoto Thyroiditis. Target enrollment is 97 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.